0001140361-15-025389.txt : 20150625 0001140361-15-025389.hdr.sgml : 20150625 20150625110240 ACCESSION NUMBER: 0001140361-15-025389 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150623 FILED AS OF DATE: 20150625 DATE AS OF CHANGE: 20150625 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTRX CORP CENTRAL INDEX KEY: 0000799698 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581642750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 BUSINESS PHONE: 310-826-5648 MAIL ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Cheryl CENTRAL INDEX KEY: 0001529371 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15327 FILM NUMBER: 15950946 MAIL ADDRESS: STREET 1: C/O MEDIVATION, INC. STREET 2: 201 SPEAR ST., 3RD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 3 1 doc1.xml FORM 3 X0206 3 2015-06-23 0 0000799698 CYTRX CORP CYTR 0001529371 Cohen Cheryl CYTRX CORPORATION 11726 SAN VICENTE BLVD. SUITE 650 LOS ANGELES CA 90049 1 0 0 0 Stock option (right to buy) 4.03 2015-06-23 2025-06-22 CytRx common stock 180000 D This option is Ms. Cohen's equity compensation upon being appointed as a director on CytRx's Board of Directors. The exercise price equals the closing price of CytRx common stock on June 23, 2015, the date of Ms. Cohen's appointment to the Board. Cheryl L. Cohen 2015-06-25 EX-24.1 2 exh.htm POWER OF ATTORNEY exh.htm

POWER OF ATTORNEY
 
The undersigned hereby constitutes and appoints each of Benjamin Levin and Cara Birardi, or either of them acting singly and with full power of substitution, as the true and lawful attorneys-in-fact and agents of the undersigned:  (1) to prepare and execute for and on behalf of the undersigned, Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to prepare and execute any such Form 3, 4, or 5, prepare and execute any amendment or amendments thereto, and timely file such form with the United States Securities and Exchange Commission (“SEC”) and any stock exchange or similar authority, including without limitation the application for EDGAR access codes and the filing of a Form ID or any other documents necessary or appropriate to enable the undersigned to file the Forms 3, 4 and 5 electronically with the SEC; and (3) to take any other action of any type whatsoever in connection with the foregoing which, in the opinion of any such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by any such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
 
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that each attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.
 
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Section 16(a) or Section 16(b) of the Securities Exchange Act of 1934 or the rules thereunder.
 
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by CytRx Corporation, unless earlier revoked by the undersigned in a signed writing delivered to all attorneys-in-fact.
 
IN WITNESS WHEREOF, the undersigned has duly executed this Power of Attorney.
 
     
       
Date: June 24, 2015
By:
/s/ Cheryl Cohen  
    Cheryl Cohen  
    Director